Related Experiment Video
Updated: May 9, 2025
Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
Published on: May 13, 2016
Felty syndrome with liver cirrhosis: A case report
Chengyi Wan1, Mei Wu1, Limei Jiang2
1Department of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Rationale:
Felty syndrome (FS) is a rare type of rheumatoid arthritis, and its combined occurrence with liver cirrhosis was rarely reported. FS was easily misdiagnosed as autoimmune cirrhosis or myelodysplastic syndrome, which led to improper medication and serious consequences.
Patient Concerns:
A 72-year-old male patient was admitted to Shuguang Hospital Affiliated with the Shanghai University of Traditional Chinese Medicine due to recurrent fatigue associated with a cough. Imaging suggested liver cirrhosis and splenomegaly, according to imaging diagnosis, laboratory tests, ultrasound, magnetic resonance, and history of rheumatoid arthritis, we considered the diagnosis of liver cirrhosis due to FS. Immunomodulatory and anti-liver fibrosis therapy was carried out, combined with Chinese patent medicines, and the patient's condition was stable in the future years.
Diagnoses:
FS, liver cirrhosis, and chronic renal insufficiency.
Interventions:
Routine immunomodulation, liver protection, and anti-liver fibrosis treatment, moreover Traditional Chinese Medicine was used to protect the liver and promote bile excretion, and regulate immunity.
Outcomes:
The patient's symptoms improved and his subsequent condition stabilized.
Lessons:
Physicians should have a better understanding of FS and know that it can lead to liver cirrhosis, to avoid misdiagnosis and poor response to glucocorticoids, delay the disease, and increase the burden on patients.
More Related Videos
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
01:30Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...